- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06642896
Quantitative Pupillometry in Brain Injury Children : Variation After Osmotherapy (OSMOPUPILLO)
Intracranial hypertension (ICH) is a common and serious complication in children admitted to pediatric intensive care units. It is primarily caused by traumatic brain injury but can also result from brain malformations, brain tumors, or neuro-meningeal infections. Rapid identification of ICH in acute settings is crucial to ensure prompt management and mitigate potential consequences, such as severe neurological sequelae or death.
The assessment of the pupillary light reflex is one of the key clinical parameters used to identify ICH in children with neurological injuries. This clinical sign is correlated with neurological prognosis. During an episode of ICH, regardless of the underlying cause, the oculomotor nerve becomes compressed between the midbrain and the temporal lobe, leading to anisocoria (unequal pupil sizes) and loss of pupillary reactivity. Other factors, such as episodes of ischemia or hypoperfusion in the midbrain, can also contribute to decreased pupillary reactivity.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Traditionally, the pupillary light reflex is assessed using a simple light source, with subjective evaluation by a healthcare professional. However, this method has significant inter- and intra-individual variability. Quantitative pupillometry offers a more objective and reproducible way to evaluate pupillary reactivity. In adults, some parameters are well-known indicators of ICH, such as a constriction velocity of less than 0.6 mm/sec and a constriction percentage below 10%. The constriction percentage can be simplified with the Neurological Pupil index (NPI), which ranges from 0 to 5. An NPI of 4 or 5 is considered to indicate good pupillary reactivity. The two quantitative pupillometers currently on the market (Neurolight, Neuroptics) appear to provide similar data for most variables assessed. However, there are few studies evaluating this tool in pediatric patients with neurological injuries.
One study on quantitative pupillometry found that children with neurological injuries and an intracranial pressure (ICP) above 20 mmHg had significantly lower pupillary reactivity, NPI, constriction percentage, and dilation and constriction velocities compared to children without ICH.
Osmotherapy is a commonly used pharmacological intervention in pediatrics to lower intracranial pressure and improve cerebral perfusion pressure. Based on the work of Freeman et al., we hypothesize that the pupillary constriction percentage improves after osmotherapy in children with neurological injuries.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Sarah SS SINTZEL STRIPPPOLI, Doctor
- Phone Number: +33 0476766729
- Email: ssintzelstrippoli@chu-grenoble.fr
Study Contact Backup
- Name: Angélina AP POLLET, RESEARCH NURSE
- Phone Number: +33 0476766729
- Email: apollet@chu-grenoble.fr
Study Locations
-
-
-
La tronche, France, 38700
- Not yet recruiting
- Grenoble Alpes University Hospital
-
Contact:
- Angelina Pollet, Research Nurse
- Phone Number: +33 0476766729
- Email: apollet@chu-grenoble.fr
-
-
Isere
-
Grenoble, Isere, France, 387000
- Recruiting
- Chu Grenoble Alpes
-
Contact:
- SARAH SS SINTZEL STRIPPOLI, PRINCIPAL INVESTIGATOR
- Phone Number: +33 +33 4 76 76 67 29
- Email: ssintzelstrippoli@chu-grenoble.fr
-
Contact:
- ANGELINA AP POLLET, RESEARCH NURSE
- Phone Number: +33 +33 4 76 76 67 29
- Email: apollet@chu-grenoble.fr
-
Contact:
- SARAH ss SINTZEL STRIPPOLI, Doctor
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Hospitalized in a pediatric intensive care unit or neurosurgical intensive care unit
- Inclusion within 24 hours of ICU admission
- with clinically suspected HTIC (disorders of consciousness with transcranial Doppler abnormality, symptoms of involvement, poor cerebral perfusion pressure) for which osmotherapy is prescribed
Exclusion Criteria:
- Presence of eye damage (or antecedent)
- Refusal by parents and/or child Opposition by child or parental guardians.
- Persons not affiliated to the social security system.
- Protected persons (under guardianship, curatorship, pregnant or breast- feeding women, persons deprived of their liberty, persons not subject to a psychiatric measure
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
severe head trauma in children with osmotherapy treatment
Admission to the pediatric intensive care or neurosurgical intensive care unit, pupillometry measurement before and after osmotherapy treatment
|
Pupillometry measurements at 5 and 25 minutes for children treated with osmotherapy, followed by measurements twice a day during hospitalization in the intensive care unit
describe the feasibility of pupillometry measurements in sedated but non-cerebrosed children in intensive care and the operating room
|
|
pupillometry measurement in non-cerebral pediatric patients
feasibility of pupillometry in children for different age groups and obtain baseline values for non-neurologically sedated children in 4 age groups from 0 to 17 years of age in intensive care and the operating room
|
Pupillometry measurements at 5 and 25 minutes for children treated with osmotherapy, followed by measurements twice a day during hospitalization in the intensive care unit
describe the feasibility of pupillometry measurements in sedated but non-cerebrosed children in intensive care and the operating room
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
to describe and evaluate the variation in the percentage of pupillary constriction (CON) before, and after osmotherapy in neuro-injured children.
Time Frame: at 10 days
|
Delta (in percentage difference, and in delta of values) of the constriction (CON) between the last available measurement before the osmotherapy was started, and the measurement 5 minutes after the end (at 25 minutes after the start of the osmotherapy). For each child, the eye with the lowest constriction (CON) value before osmotherapy will be considered. |
at 10 days
|
|
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
|
Success rate in obtaining pupillometric values for different age groups.
Pupillometric values: QPI (quantitative pupillometry index) in intensive care and the operating room
|
at 1 minute and 25 minutes
|
|
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
|
Success rate in obtaining pupillometric values for different age groups.
Pupillometric values: latency (LAT) in intensive care and the operating room
|
at 1 minute and 25 minutes
|
|
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
|
Success rate in obtaining pupillometric values for different age groups.
Pupillometric values: constriction velocity (ACV) and dilatation velocity (ADV) in mm/sec in intensive care and the operating room
|
at 1 minute and 25 minutes
|
|
Describe the feasibility of pupillometry in children for different age groups, and obtain baseline values for the sedated, non-neurosed child.
Time Frame: at 1 minute and 25 minutes
|
Success rate in obtaining pupillometric values for different age groups.
Pupillometric values: minimum (MIN) and maximum (MAX) pupillary diameter in mm in intensive care and the operating room
|
at 1 minute and 25 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (LAT).
Time Frame: per 12h during 10 days
|
Assessing the association between latency in sec (LAT) and ICP (mmhg)
|
per 12h during 10 days
|
|
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (QPI).
Time Frame: per 12h during 10 days
|
Assessing the association between measurements of pupillometry, QPI, quantitative pupillometry index
|
per 12h during 10 days
|
|
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if ICP more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values.(CON)
Time Frame: per 12h during 10 days
|
Assessing the association between measurements of pupillometry, percentage of constriction (CON) and ICP.
|
per 12h during 10 days
|
|
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values (Max; Min)
Time Frame: per 12h during 10 days
|
To asses association between intracranial pressure and minimum et maximum pupillary diameter (in mm).
|
per 12h during 10 days
|
|
In the age subgroup of children with an intracranial pressure (ICP) sensor (pathological if more than 20mmHg), evaluate the relationship between intracranial pressure and the various pupillometry values. (ACV and ADV)
Time Frame: per 12h during 10 days
|
To asses association between ICP and pupillometry values : constriction velocity (ACV) and dilatation velocity (ADV) in mm.sec
|
per 12h during 10 days
|
|
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age
Time Frame: at 1 and 25 minutes
|
measurement of pupillometric parameters : latence (in sec)
|
at 1 and 25 minutes
|
|
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 minutes
|
measurement of pupillometric parameters : quantitative pupillometry index, pupil constriction
|
at 1 and 25 minutes
|
|
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 minutes
|
measurement of pupillometric parameters : Minimum and maximum pupillary diameter (in mm)
|
at 1 and 25 minutes
|
|
Comparison of pupillometry values between neuro-sedated and non-neuro-sedated children, adjusting for age.
Time Frame: at 1 and 25 min
|
measurement of pupillometric parameters constriction velocity (ACV), dilatation velocity (ADV) in mm/sec
|
at 1 and 25 min
|
|
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes
|
Measure of pupillometry: CON and QPI after osmotherapy administration
|
at 15 , 25, 35, 45, 60, 120, 240 minutes
|
|
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: [Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
|
Measure of pupillometry : constriction velocity (ACV), dilatation velocity (ADV) in mm/sec
|
[Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
|
|
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: [Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
|
Measure of pupillometry: latence (in mm)
|
[Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes]
|
|
Describe the evolution of different pupillometry measurements before and after osmotherapy
Time Frame: at 15 , 25, 35, 45, 60, 120, 240 minutes
|
Measure of pupillometry: Min and max pupillary diameter in mm.
|
at 15 , 25, 35, 45, 60, 120, 240 minutes
|
|
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
|
Repeated pupillometry measurements : (LAT) latence in sec and transcranial doppler
|
2 times a day for 10 days or on discharge from hospital
|
|
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
|
Repeated pupillometry measurements QPI and CON and transcranial doppler
|
2 times a day for 10 days or on discharge from hospital
|
|
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
|
Repeated pupillometry measurements (Maximum and minimum pupillary diameter in mm) and transcranial doppler
|
2 times a day for 10 days or on discharge from hospital
|
|
Assessing the relationship between transcranial Doppler (CTD) results: pulsatility index (PI) and diastolic velocity (Vd)
Time Frame: 2 times a day for 10 days or on discharge from hospital
|
Repeated pupillometry measurements (constriction velocity (ACV) and dilatation velocity (ADV) in mm.sec) and transcranial doppler
|
2 times a day for 10 days or on discharge from hospital
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Boev AN, Fountas KN, Karampelas I, Boev C, Machinis TG, Feltes C, Okosun I, Dimopoulos V, Troup C. Quantitative pupillometry: normative data in healthy pediatric volunteers. J Neurosurg. 2005 Dec;103(6 Suppl):496-500. doi: 10.3171/ped.2005.103.6.0496.
- Winston M, Zhou A, Rand CM, Dunne EC, Warner JJ, Volpe LJ, Pigneri BA, Simon D, Bielawiec T, Gordon SC, Vitez SF, Charnay A, Joza S, Kelly K, Panicker C, Rizvydeen S, Niewijk G, Coleman C, Scher BJ, Reed DW, Hockney SM, Buniao G, Stewart T, Trojanowski L, Brogadir C, Price M, Kenny AS, Bradley A, Volpe NJ, Weese-Mayer DE. Pupillometry measures of autonomic nervous system regulation with advancing age in a healthy pediatric cohort. Clin Auton Res. 2020 Feb;30(1):43-51. doi: 10.1007/s10286-019-00639-3. Epub 2019 Sep 25.
- Rouche O, Wolak-Thierry A, Destoop Q, Milloncourt L, Floch T, Raclot P, Jolly D, Cousson J. Evaluation of the depth of sedation in an intensive care unit based on the photo motor reflex variations measured by video pupillometry. Ann Intensive Care. 2013 Feb 22;3(1):5. doi: 10.1186/2110-5820-3-5.
- Freeman AD, McCracken CE, Stockwell JA. Automated Pupillary Measurements Inversely Correlate With Increased Intracranial Pressure in Pediatric Patients With Acute Brain Injury or Encephalopathy. Pediatr Crit Care Med. 2020 Aug;21(8):753-759. doi: 10.1097/PCC.0000000000002327.
- Robba C, Moro Salihovic B, Pozzebon S, Creteur J, Oddo M, Vincent JL, Taccone FS. Comparison of 2 Automated Pupillometry Devices in Critically III Patients. J Neurosurg Anesthesiol. 2020 Oct;32(4):323-329. doi: 10.1097/ANA.0000000000000604.
- Bower MM, Sweidan AJ, Xu JC, Stern-Neze S, Yu W, Groysman LI. Quantitative Pupillometry in the Intensive Care Unit. J Intensive Care Med. 2021 Apr;36(4):383-391. doi: 10.1177/0885066619881124. Epub 2019 Oct 10.
- Ritter AM, Muizelaar JP, Barnes T, Choi S, Fatouros P, Ward J, Bullock MR. Brain stem blood flow, pupillary response, and outcome in patients with severe head injuries. Neurosurgery. 1999 May;44(5):941-8. doi: 10.1097/00006123-199905000-00005.
- Manley GT, Larson MD. Infrared pupillometry during uncal herniation. J Neurosurg Anesthesiol. 2002 Jul;14(3):223-8. doi: 10.1097/00008506-200207000-00009.
- Rameshkumar R, Bansal A, Singhi S, Singhi P, Jayashree M. Randomized Clinical Trial of 20% Mannitol Versus 3% Hypertonic Saline in Children With Raised Intracranial Pressure Due to Acute CNS Infections. Pediatr Crit Care Med. 2020 Dec;21(12):1071-1080. doi: 10.1097/PCC.0000000000002557.
- Piper BJ, Harrigan PW. Hypertonic saline in paediatric traumatic brain injury: a review of nine years' experience with 23.4% hypertonic saline as standard hyperosmolar therapy. Anaesth Intensive Care. 2015 Mar;43(2):204-10. doi: 10.1177/0310057X1504300210.
- Kochanek PM, Adelson PD, Rosario BL, Hutchison J, Miller Ferguson N, Ferrazzano P, O'Brien N, Beca J, Sarnaik A, LaRovere K, Bennett TD, Deep A, Gupta D, Willyerd FA, Gao S, Wisniewski SR, Bell MJ; ADAPT Investigators. Comparison of Intracranial Pressure Measurements Before and After Hypertonic Saline or Mannitol Treatment in Children With Severe Traumatic Brain Injury. JAMA Netw Open. 2022 Mar 1;5(3):e220891. doi: 10.1001/jamanetworkopen.2022.0891.
- Rallis D, Poulos P, Kazantzi M, Chalkias A, Kalampalikis P. Effectiveness of 7.5% hypertonic saline in children with severe traumatic brain injury. J Crit Care. 2017 Apr;38:52-56. doi: 10.1016/j.jcrc.2016.10.014. Epub 2016 Oct 21.
- Melo JR, Di Rocco F, Blanot S, Cuttaree H, Sainte-Rose C, Oliveira-Filho J, Zerah M, Meyer PG. Transcranial Doppler can predict intracranial hypertension in children with severe traumatic brain injuries. Childs Nerv Syst. 2011 Jun;27(6):979-84. doi: 10.1007/s00381-010-1367-8. Epub 2011 Jan 5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 38RC24.0212
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Children Brain Injury
-
Ain Shams UniversityUnknownMental Handicap | Cerebral Palsy Children | Children With Traumatic Brain Injury | Delayed Speech DevelopmentEgypt
-
Princess Nourah Bint Abdulrahman UniversityActive, not recruitingChildren With Acquired Brain InjurySaudi Arabia
-
University of Sao PauloBoston Children's HospitalUnknownChildren | Traumatic Brain InjuryBrazil
-
Johns Hopkins UniversityNational Institute of Neurological Disorders and Stroke (NINDS)CompletedExtracorporeal Membrane Oxygenation | Children | Neurologic InjuryUnited States
-
Yonsei UniversityCompletedCerebral Palsy | Children With Brain InjuryKorea, Republic of
-
University of Alabama at BirminghamCompletedSport Injury | Concussion, Mild | Concussion, Brain | Concussion, Severe | Sports Injuries in Children | Concussive InjuryUnited States
-
MarsiBionicsHospital General Universitario Gregorio Marañon; Hospital Infantil Universitario... and other collaboratorsCompletedCerebral Palsy | Acquired Brain Injury | Neuromuscular Diseases in ChildrenSpain
-
Dr. Michael EsserNeuroCatch Inc.UnknownTraumatic Brain Injury | Pediatric ALL | Children, Only | Concussion, MildCanada
-
Tianjin First Central HospitalUnknownLiver Transplantation | ChildrenChina
-
University of Alabama at BirminghamCompleted
Clinical Trials on pupillometer
-
Wills EyeCompleted
-
Basque Health ServiceActive, not recruiting
-
Second Affiliated Hospital, School of Medicine,...CompletedMental Fatigue | Emergency Paramedics' FatigueChina
-
Centre Hospitalier Universitaire de la RéunionCompletedAll Indication for External Ventricular Drain ClampingFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University of CalgaryNot yet recruitingHypoxic Ischemic Encephalopathy (HIE)Canada
-
Sheba Medical CenterRecruitingPseudotumor CerebriIsrael
-
M.D. Anderson Cancer CenterRecruitingNeurotoxicityUnited States
-
Wonju Severance Christian HospitalSeoul National University Bundang HospitalCompletedCarbon Monoxide PoisoningKorea, Republic of
-
Centre Hospitalier Universitaire de Saint EtienneCompleted